malini_moorthy

Bayer hires litigation head from Pfizer

pharmafile | July 17, 2014 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Malini Moorthy, Pfizer 

Bayer Healthcare has appointed Malini Moorthy to head up its litigation department in the US. 

Moorthy joins the German firm from Pfizer where she held leadership roles in the company’s litigation group for 10 years. Most recently, she served as VP and assistant general counsel and head of civil litigation.

Moorthy will be responsible for managing and directing all major litigation matters for Bayer and its US operating companies, including: Bayer HealthCare, Bayer MaterialScience and Bayer CropScience.

Advertisement

She succeeds Kaspar Stoffelmayr whose three-year assignment ended and has rejoined law firm Bartlit Beck Herman Palenchar & Scott. Moorthy will report directly to Lars Benecke, general counsel, company secretary and compliance officer for Bayer.

Prior to joining Pfizer Moorthy spent many years as a litigation associate at law firms in the US and Canada, including the New York office of Salans, now known as Dentons, and Genest Murray Desbrisay Lamek and McCarthy Tetrault, both in Toronto. 

“I have long admired Bayer and its commitment to use science and innovation to improve the quality of life,” Moorthy says. “I am delighted to be joining a company with such a meaningful mission and such a strong and dedicated leadership team and culture that is committed to ensuring that it is fulfilled.”

Related Content

Evotec and Bayer announce new kidney disease study

Evotec and Bayer have announced the initiation of a phase 2 clinical study in kidney …

NICE recommends Pfizer’s new once-weekly treatment for haemophilia B on NHS

Walton Oaks, 21st May 2025 – Pfizer Ltd announced today that the National Institute for Health and Care …

Third application for Orion’s prostate cancer drug submitted by partner Bayer

Finnish pharmaceutical company Orion has announced that its partner Bayer is applying for a third application …

The Gateway to Local Adoption Series

Latest content